Acura Pharmaceuticals, Inc.
ACUR
$0.00
$0.00150.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -262.00K | -387.00K | -259.00K | -243.00K | -678.00K |
| Total Depreciation and Amortization | 27.00K | 18.00K | 18.00K | 19.00K | 20.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.00K | 29.00K | -- | -214.00K | 9.00K |
| Change in Net Operating Assets | 411.00K | 146.00K | -72.00K | 358.00K | 104.00K |
| Cash from Operations | 191.00K | -194.00K | -313.00K | -80.00K | -545.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 266.00K | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 3.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | 0.00 | -8.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -269.00K | -- | -- | -- | -- |
| Cash from Financing | -269.00K | 0.00 | 261.00K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.00K | -194.00K | -52.00K | -80.00K | -545.00K |